로딩 중…
지수 로딩 중…
OSTEONIC Co., Ltd.
226400· KOSDAQ· Health Care· Health Care Equipment & Services
₩5,050+2.85%
2026-08-04
Financials
Valuation Metrics
OSTEONIC Co., Ltd.'s Market Cap is ₩1043B. At end of 2025 it was ₩1285B. Ranked #1221 of 2,436 in KR market (top 50%), #653 of 1,649 on KOSDAQ (top 40%), #43 of 96 in Health Care Equipment & Services (top 45%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 104.34B KRW | KR#1,221/2,436 Sec#43/96 |
| Revenue | 48.77B KRW | KR#1,790/2,436 Sec#52/96 |
| Net Income | 9.39B KRW | KR#927/2,436 Sec#26/96 |
| Total Assets | 111.41B KRW | KR#1,672/2,436 Sec#51/96 |
| Net Assets | 70.23B KRW | KR#1,647/2,436 Sec#52/96 |
| Employees | 179 | KR#1,165/2,436 Sec#35/96 |
| Value | ||
| P/E | 11.11x | KR#775/2,436 Sec#22/96 |
| P/B | 1.49x | KR#1,784/2,436 Sec#59/96 |
| PEG | 0.04x | KR#247/2,436 Sec#9/96 |
| P/S | 2.14x | KR#1,862/2,436 Sec#53/96 |
| EV/EBITDA | 11.24x | KR#677/2,436 Sec#22/96 |
| FCF Yield | 0.31% | KR#1,194/2,436 Sec#32/96 |
| Profitability | ||
| ROE | 13.37% | KR#311/2,436 Sec#16/96 |
| ROA | 8.43% | KR#294/2,436 Sec#18/96 |
| Op. Margin | 19.89% | KR#155/2,436 Sec#15/96 |
| Revenue Growth | 35.39% | KR#413/2,436 Sec#15/96 |
| Earnings Growth | 248.38% | KR#205/2,436 Sec#9/96 |
| Financial Health | ||
| Debt Ratio | 158.62% | KR#1,301/2,436 Sec#69/96 |
| Total Debt | 19.14B KRW | KR#1,370/2,436 Sec#42/96 |
| FCF | 323.6M KRW | KR#1,200/2,436 Sec#33/96 |
| Cash | 14.47B KRW | KR#1,439/2,436 Sec#45/96 |
| Current Ratio | 2.18x | KR#859/2,436 Sec#47/96 |
| Net Debt/EBITDA | 0.48x | KR#743/2,436 Sec#31/96 |
| Performance | ||
| 1Y Return | -24.17% | KR#1,411/2,436 Sec#43/96 |
| 1M Return | 12.22% | KR#231/2,436 Sec#15/96 |
| From 52W High | -38.34% | KR#685/2,436 Sec#23/96 |
| 1Y MDD | -53.99% | KR#1,110/2,436 Sec#40/96 |
| Trading | ||
| Volume | 151,918 shares | KR#716/2,436 Sec#28/96 |
| Foreign Own. | 7.14% | KR#614/2,436 Sec#17/96 |
| Per Share | ||
| EPS | 455 KRW | KR#945/2,436 Sec#25/96 |
| BPS | 3,495 KRW | KR#1,714/2,436 Sec#46/96 |
Company Info
Osteonick, established in 2012, specializes in the development, manufacturing, and sale of orthopedic implants, and was listed on KOSDAQ in 2018. The company produces metal and biomaterial-based implants across all orthopedic fields, supplying medical devices for the fixation, replacement, and adjustment of fractured bones. It has secured vertically integrated process technology, collaborates with B. Braun, and is pursuing FDA and CE approvals to expand into global markets. Osteonick is headquartered in Guro-gu, Seoul.